# Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme.

> **NCT00645385** · — · WITHDRAWN · sponsor: **Weill Medical College of Cornell University**

## Conditions studied

- Glioblastoma Multiforme
- Anaplastic Astrocytoma
- Anaplastic Oligodendroglioma

## Interventions

- **OTHER:** MRS Spectroscopy

## Key facts

- **NCT ID:** NCT00645385
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-06
- **Primary completion:** 2011-06-01
- **Final completion:** 2011-06-01
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2019-06-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00645385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00645385, "Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00645385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*